Colgate-Palmolive (CL) Financials

$83.44 -1.01 (-1.20%)

Closing price 08/28/2025 03:59 PM Eastern

Extended Trading

$83.76 +0.32 (+0.38%)

As of 07:24 AM Eastern

Annual Income Statements for Colgate-Palmolive

This table shows Colgate-Palmolive's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	2,180	1,384	2,441	2,024	2,400	2,367	2,695	2,166	1,785	2,300	2,889
Consolidated Net Income / (Loss)	2,339	1,548	2,586	2,174	2,558	2,527	2,860	2,338	1,967	2,455	3,049
Net Income / (Loss) Continuing Operations	2,339	1,548	2,586	2,174	2,558	2,527	2,860	2,338	1,967	2,455	3,049
Total Pre-Tax Income	3,533	2,763	3,738	3,487	3,464	3,301	3,647	3,087	2,660	3,392	3,956
Total Operating Income	3,557	2,789	3,955	3,707	3,694	3,554	3,885	3,332	2,893	3,984	4,268
Total Gross Profit	10,109	9,399	9,123	9,280	9,231	9,325	10,017	10,375	10,248	11,326	12,161
Total Revenue	17,277	16,034	15,195	15,454	15,544	15,693	16,471	17,421	17,967	19,457	20,101
Operating Revenue	17,277	16,034	15,195	15,454	15,544	15,693	16,471	17,421	17,967	19,457	20,101
Total Cost of Revenue	7,168	6,635	6,072	6,174	6,313	6,368	6,454	7,046	7,719	8,131	7,940
Operating Cost of Revenue	7,168	6,635	6,072	6,174	6,313	6,368	6,454	7,046	7,719	8,131	7,940
Total Operating Expenses	6,552	6,610	5,168	5,573	5,537	5,771	6,132	7,043	7,355	7,342	7,893
Selling, General & Admin Expense	5,982	5,464	5,143	5,400	5,389	5,575	6,019	6,407	6,565	7,151	7,729
Other Operating Expenses / (Income)	570	1,146	25	173	148	196	113	65	69	191	164
Impairment Charge	-	-	-	-	-	0.00	0.00	571	721	0.00	0.00
Total Other Income / (Expense), net	-24	-26	-217	-220	-230	-253	-238	-245	-233	-592	-312
Interest Expense	24	26	99	220	143	145	164	175	167	287	292
Interest & Investment Income	-	-	-	-	-	-	-	-	14	55	67
Other Income / (Expense), net	-	-	-118	-	-87	-108	-74	-70	-80	-360	-87
Income Tax Expense	1,194	1,215	1,152	1,313	906	774	787	749	693	937	907
Net Income / (Loss) Attributable to Noncontrolling Interest	159	164	145	150	158	160	165	172	182	155	160
Basic Earnings per Share	$2.38	$1.53	$2.74	$2.30	$2.76	$2.76	$3.15	$2.56	$2.13	$2.78	$3.53
Weighted Average Basic Shares Outstanding	915.10M	902.20M	891.80M	881.80M	870.60M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M
Diluted Earnings per Share	$2.36	$1.52	$2.72	$2.28	$2.75	$2.75	$3.14	$2.55	$2.13	$2.77	$3.51
Weighted Average Diluted Shares Outstanding	915.10M	902.20M	891.80M	881.80M	870.60M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M
Weighted Average Basic & Diluted Shares Outstanding	915.10M	902.20M	891.80M	881.80M	870.60M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M
Cash Dividends to Common per Share	-	-	-	$1.59	$1.66	$1.71	$1.75	$1.79	$1.86	$1.91	$2.48

This table shows Colgate-Palmolive's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	5.00	372	502	708	718	683	731	737	738	690	743
Consolidated Net Income / (Loss)	43	414	534	747	760	729	767	776	777	726	773
Net Income / (Loss) Continuing Operations	43	414	534	747	760	729	767	776	777	726	773
Total Pre-Tax Income	132	561	887	956	988	967	1,010	986	993	953	1,007
Total Operating Income	202	909	974	1,029	1,072	1,047	1,092	1,065	1,064	1,076	1,080
Total Gross Profit	2,574	2,712	2,787	2,877	2,950	3,039	3,066	3,074	2,982	2,987	3,069
Total Revenue	4,629	4,770	4,822	4,915	4,950	5,065	5,058	5,033	4,945	4,911	5,110
Operating Revenue	4,629	4,770	4,822	4,915	4,950	5,065	5,058	5,033	4,945	4,911	5,110
Total Cost of Revenue	2,055	2,058	2,035	2,038	2,000	2,026	1,992	1,959	1,963	1,924	2,041
Operating Cost of Revenue	2,055	2,058	2,035	2,038	2,000	2,026	1,992	1,959	1,963	1,924	2,041
Total Operating Expenses	2,372	1,803	1,813	1,848	1,878	1,992	1,974	2,009	1,918	1,911	1,989
Selling, General & Admin Expense	1,633	1,758	1,768	1,822	1,803	1,916	1,939	1,979	1,895	1,898	1,963
Other Operating Expenses / (Income)	18	45	45	26	75	76	35	30	23	13	26
Total Other Income / (Expense), net	-70	-348	-87	-73	-84	-80	-82	-79	-71	-123	-73
Interest Expense	69	54	29	-	-	73	78	23	189	66	71
Interest & Investment Income	-	-	-58	-58	-	15	18	-56	-	15	21
Other Income / (Expense), net	-15	-294	-	-15	-	-22	-22	-	-	-72	-23
Income Tax Expense	89	147	353	209	228	238	243	210	216	227	234
Net Income / (Loss) Attributable to Noncontrolling Interest	38	42	32	39	42	46	36	39	39	36	30
Basic Earnings per Share	-	$0.45	$0.61	$0.86	$0.86	$0.83	$0.89	$0.90	$0.91	$0.85	$0.92
Weighted Average Basic Shares Outstanding	830.38M	829.57M	826.69M	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M	810.42M	808.22M
Diluted Earnings per Share	$0.01	$0.45	$0.60	$0.86	$0.86	$0.83	$0.89	$0.90	$0.89	$0.85	$0.91
Weighted Average Diluted Shares Outstanding	830.38M	829.57M	826.69M	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M	810.42M	808.22M
Weighted Average Basic & Diluted Shares Outstanding	830.38M	829.57M	826.69M	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M	810.42M	808.22M
Cash Dividends to Common per Share	-	$0.95	$0.48	$0.48	-	$0.98	$0.50	$0.50	-	$0.52	$0.52

This table details how cash moves in and out of Colgate-Palmolive's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	127	-119	345	133	-793	157	5.00	-56	-57	191	130
Net Cash From Operating Activities	3,298	2,949	3,141	3,054	3,056	3,133	3,719	3,325	2,556	3,745	4,107
Net Cash From Continuing Operating Activities	3,298	2,949	3,141	3,054	3,056	3,133	3,719	3,325	2,556	3,745	4,107
Net Income / (Loss) Continuing Operations	2,339	1,548	2,586	2,174	2,558	2,527	2,860	2,338	1,967	2,455	3,049
Consolidated Net Income / (Loss)	2,339	1,548	2,586	2,174	2,558	2,527	2,860	2,338	1,967	2,455	3,049
Depreciation Expense	442	449	443	475	511	519	539	556	545	567	605
Non-Cash Adjustments To Reconcile Net Income	586	1,125	-36	137	115	5.00	59	760	848	366	186
Changes in Operating Assets and Liabilities, net	-69	-173	148	268	-128	82	261	-329	-804	357	267
Net Cash From Investing Activities	-859	-685	-499	-471	-1,170	-2,099	-779	-592	-1,601	-742	-534
Net Cash From Continuing Investing Activities	-859	-685	-499	-471	-1,170	-2,099	-779	-592	-1,601	-742	-534
Purchase of Property, Plant & Equipment	-757	-691	-593	-553	-436	-335	-410	-567	-696	-705	-561
Acquisitions	-87	-13	-5.00	0.00	-728	-1,711	-353	0.00	-809	0.00	0.00
Purchase of Investments	-340	-742	-336	-347	-169	-184	-143	-141	-470	-506	-574
Sale of Property, Plant & Equipment	0.00	0.00	60	-	-	-	0.00	0.00	47	0.00	0.00
Sale and/or Maturity of Investments	283	599	378	391	156	131	124	141	322	502	564
Other Investing Activities, net	18	-68	-3.00	-6.00	7.00	0.00	3.00	-25	5.00	-33	37
Net Cash From Financing Activities	-2,170	-2,276	-2,233	-2,450	-2,679	-870	-2,919	-2,774	-952	-2,793	-3,389
Net Cash From Continuing Financing Activities	-2,170	-2,276	-2,233	-2,450	-2,679	-870	-2,919	-2,774	-952	-2,793	-3,389
Repayment of Debt	-8,525	-9,181	-7,274	-4,808	-725	-1,426	-564	-898	116	-1,791	-410
Repurchase of Common Equity	-1,530	-1,551	-1,335	-1,399	-1,238	-1,202	-1,476	-1,320	-1,308	-1,128	-1,739
Payment of Dividends	-1,446	-1,493	-1,508	-1,529	-1,591	-1,614	-1,753	-1,679	-1,691	-1,749	-1,789
Issuance of Debt	8,960	9,602	7,438	4,779	546	2,874	0.00	699	1,513	1,495	-89
Other Financing Activities, net	371	347	446	507	329	498	874	424	418	380	638
Effect of Exchange Rate Changes	-142	-107	-64	-	-	-7.00	-16	-15	-60	-19	-54
Cash Interest Paid	133	131	162	150	194	185	188	194	151	280	302
Cash Income Taxes Paid	1,009	1,259	932	1,037	847	803	845	890	945	937	933

This table details how cash moves in and out of Colgate-Palmolive's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Net Change in Cash & Equivalents	-163	92	-48	132	15	113	31	124	-138	16	103
Net Cash From Operating Activities	673	735	722	1,152	1,136	681	990	1,167	1,269	600	884
Net Cash From Continuing Operating Activities	673	735	722	1,152	1,136	681	990	1,167	1,269	600	884
Net Income / (Loss) Continuing Operations	43	414	534	747	760	729	766	775	779	726	773
Consolidated Net Income / (Loss)	43	414	534	747	760	729	766	775	779	726	773
Depreciation Expense	135	128	145	144	150	150	157	150	148	148	151
Non-Cash Adjustments To Reconcile Net Income	739	274	22	51	19	49	42	71	24	81	26
Changes in Operating Assets and Liabilities, net	-244	-81	21	210	207	-247	25	171	318	-355	-66
Net Cash From Investing Activities	-173	-264	-174	-161	-143	-193	-111	-150	-80	-159	-401
Net Cash From Continuing Investing Activities	-173	-264	-174	-161	-143	-193	-111	-150	-80	-159	-401
Purchase of Property, Plant & Equipment	-221	-163	-184	-161	-197	-126	-117	-134	-184	-124	-108
Purchase of Investments	-231	-112	-113	-99	-182	-139	-104	-115	-216	-134	-250
Sale and/or Maturity of Investments	267	14	132	118	238	78	100	82	304	97	253
Other Investing Activities, net	4.00	-3.00	-9.00	-19	-2.00	-6.00	10	17	16	2.00	-3.00
Net Cash From Financing Activities	-666	-375	-580	-846	-992	-361	-845	-904	-1,279	-458	-409
Net Cash From Continuing Financing Activities	-666	-375	-580	-846	-992	-361	-845	-904	-1,279	-458	-409
Repayment of Debt	212	-1,422	109	-184	-294	205	-12	-357	-246	192	-225
Repurchase of Common Equity	-413	-180	-371	-332	-245	-509	-480	-295	-455	-284	-232
Payment of Dividends	-485	-390	-457	-396	-506	-394	-473	-408	-514	-406	-474
Issuance of Debt	-	1,495	2.00	-	-2.00	1.00	1.00	-	-91	0.00	497
Other Financing Activities, net	20	122	137	66	55	336	119	156	27	40	25
Effect of Exchange Rate Changes	3.00	-4.00	-16	-13	14	-14	-3.00	11	-48	33	29
Cash Interest Paid	47	94	35	114	37	123	38	106	35	109	28
Cash Income Taxes Paid	255	171	279	276	211	150	355	257	171	139	391

This table presents Colgate-Palmolive's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	13,459	11,935	12,123	12,676	12,161	15,034	15,920	15,040	15,731	16,393	16,046
Total Current Assets	4,863	4,384	4,338	4,639	3,793	4,179	4,338	4,397	5,113	5,279	5,317
Cash & Equivalents	1,089	970	1,315	1,535	726	883	888	832	775	966	1,096
Accounts Receivable	1,552	1,427	1,411	1,480	1,400	1,440	1,264	1,297	1,504	1,586	1,521
Inventories, net	1,382	1,180	1,171	1,221	1,250	1,400	1,673	1,692	2,074	1,934	1,987
Other Current Assets	840	807	441	403	417	456	513	576	760	793	713
Plant, Property, & Equipment, net	4,080	3,796	3,840	4,072	3,881	3,750	3,716	3,730	4,307	4,582	4,422
Plant, Property & Equipment, gross	-	-	-	-	-	-	-	-	-	-	10,127
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	5,705
Total Noncurrent Assets	4,516	3,755	3,945	3,965	4,487	7,105	7,866	6,913	6,311	6,532	6,307
Goodwill	2,307	2,103	2,107	2,218	2,530	3,508	3,824	3,284	3,352	3,410	3,272
Intangible Assets	1,413	1,346	1,313	1,341	1,637	2,667	2,894	2,462	1,920	1,887	1,756
Noncurrent Deferred & Refundable Income Taxes	76	67	301	188	152	177	291	193	135	214	195
Other Noncurrent Operating Assets	720	239	224	218	168	753	857	974	904	1,021	1,084
Total Liabilities & Shareholders' Equity	13,459	11,935	12,123	12,676	12,161	15,034	15,920	15,040	15,731	16,393	16,046
Total Liabilities	12,074	11,979	12,106	12,433	11,964	14,476	14,819	14,069	14,925	15,436	15,502
Total Current Liabilities	3,946	3,534	3,305	3,408	3,341	4,038	4,404	4,051	4,004	4,741	5,759
Short-Term Debt	504	302	13	11	12	514	267	51	25	330	660
Accounts Payable	1,231	1,110	1,124	1,212	1,222	1,237	1,393	1,479	1,551	1,698	1,805
Accrued Expenses	1,917	1,845	1,727	1,831	1,696	1,917	2,341	2,085	2,111	2,377	2,891
Current Deferred & Payable Income Tax Liabilities	294	277	441	354	411	370	403	436	317	336	403
Total Noncurrent Liabilities	8,128	8,445	8,801	9,025	8,623	10,438	10,415	10,018	10,921	10,695	9,743
Long-Term Debt	5,644	6,246	6,520	6,566	6,354	7,333	7,334	7,194	8,741	8,219	7,289
Noncurrent Deferred & Payable Income Tax Liabilities	261	233	246	204	235	507	426	395	383	361	343
Other Noncurrent Operating Liabilities	2,223	1,966	2,035	2,255	2,034	2,598	2,655	2,429	1,797	2,115	2,111
Total Equity & Noncontrolling Interests	1,385	-44	17	243	197	558	1,101	971	806	957	544
Total Preferred & Common Equity	1,145	-299	-243	-60	-102	117	743	609	401	609	212
Total Common Equity	1,145	-299	-243	-60	-102	117	743	609	401	609	212
Common Stock	2,702	2,904	3,157	3,450	3,670	3,954	4,435	4,735	5,012	5,274	5,647
Retained Earnings	18,832	18,861	19,922	20,531	21,615	22,501	23,699	24,350	24,573	25,289	26,145
Treasury Stock	-16,862	-18,102	-19,135	-20,181	-21,196	-22,063	-23,045	-24,089	-25,128	-26,017	-27,358
Accumulated Other Comprehensive Income / (Loss)	-3,507	-3,950	-4,180	-3,855	-4,188	-4,273	-4,345	-4,386	-4,055	-3,937	-4,222
Noncontrolling Interest	240	255	260	303	299	441	358	362	405	348	332

This table presents Colgate-Palmolive's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Total Assets	15,731	16,173	16,227	16,043	16,393	16,571	16,480	16,774	16,046	16,647	17,470
Total Current Assets	5,113	5,466	5,437	5,357	5,279	5,640	5,646	5,806	5,317	5,814	5,996
Cash & Equivalents	775	867	819	951	966	1,079	1,110	1,234	1,096	1,112	1,215
Accounts Receivable	1,504	1,590	1,656	1,577	1,586	1,813	1,825	1,712	1,521	1,725	1,773
Inventories, net	2,074	2,110	2,039	1,931	1,934	1,914	1,922	2,041	1,987	2,125	2,120
Other Current Assets	760	899	923	898	793	834	789	819	713	852	888
Plant, Property, & Equipment, net	4,307	4,363	4,431	4,409	4,582	4,497	4,392	4,421	4,422	4,416	4,529
Plant, Property & Equipment, gross	-	9,815	9,988	9,979	-	10,261	10,167	10,238	-	10,276	10,665
Accumulated Depreciation	-	5,452	5,557	5,570	-	5,764	5,775	5,817	-	5,860	6,136
Total Noncurrent Assets	6,311	6,344	6,359	6,277	6,532	6,434	6,442	6,547	6,307	6,417	6,945
Goodwill	3,352	3,375	3,373	3,327	3,410	3,341	3,320	3,389	3,272	3,334	3,696
Intangible Assets	1,920	1,918	1,901	1,861	1,887	1,837	1,814	1,834	1,756	1,782	1,904
Noncurrent Deferred & Refundable Income Taxes	135	179	186	202	214	222	214	219	195	211	218
Other Noncurrent Operating Assets	904	872	899	887	1,021	1,034	1,094	1,105	1,084	1,090	1,127
Total Liabilities & Shareholders' Equity	15,731	16,173	16,227	16,043	16,393	16,571	16,480	16,774	16,046	16,647	17,470
Total Liabilities	14,925	15,748	15,912	15,637	15,436	15,954	15,998	15,938	15,502	15,914	16,418
Total Current Liabilities	4,004	4,441	4,632	4,602	4,741	5,314	5,350	5,565	5,759	6,861	6,775
Short-Term Debt	25	37	35	34	330	538	530	527	660	1,698	1,614
Accounts Payable	1,551	1,609	1,544	1,482	1,698	1,646	1,557	1,625	1,805	1,800	1,790
Accrued Expenses	2,111	2,498	2,600	2,732	2,377	2,720	2,864	3,066	2,891	2,873	3,050
Current Deferred & Payable Income Tax Liabilities	317	297	453	354	336	410	399	347	403	490	321
Total Noncurrent Liabilities	10,921	11,307	11,280	11,035	10,695	10,640	10,648	10,373	9,743	9,053	9,643
Long-Term Debt	8,741	8,870	8,954	8,690	8,219	8,151	8,146	7,909	7,289	6,571	7,144
Noncurrent Deferred & Payable Income Tax Liabilities	383	421	363	430	361	392	355	320	343	302	279
Other Noncurrent Operating Liabilities	1,797	2,016	1,963	1,915	2,115	2,097	2,147	2,144	2,111	2,180	2,220
Total Equity & Noncontrolling Interests	806	425	315	406	957	617	482	836	544	733	1,052
Total Preferred & Common Equity	401	-6.00	-64	-9.00	609	230	123	435	212	363	702
Total Common Equity	401	-6.00	-64	-9.00	609	230	123	435	212	363	702
Common Stock	5,012	5,069	5,154	5,228	5,274	5,428	5,501	5,608	5,647	5,668	5,712
Retained Earnings	24,573	24,153	24,258	24,571	25,289	25,164	25,486	25,814	26,145	26,413	26,735
Treasury Stock	-25,128	-25,245	-25,541	-25,834	-26,017	-26,343	-26,736	-26,913	-27,358	-27,602	-27,821
Accumulated Other Comprehensive Income / (Loss)	-4,055	-3,983	-3,935	-3,974	-3,937	-4,019	-4,128	-4,074	-4,222	-4,116	-3,924
Noncontrolling Interest	405	431	379	415	348	387	359	401	332	370	350

This table displays calculated financial ratios and metrics derived from Colgate-Palmolive's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.82%	-7.19%	-5.23%	1.70%	0.58%	0.96%	4.96%	5.77%	3.13%	8.29%	3.31%
EBITDA Growth	0.10%	-19.03%	32.18%	-2.29%	-1.53%	-3.72%	9.71%	-12.23%	-12.05%	24.81%	14.20%
EBIT Growth	0.03%	-21.59%	37.58%	-3.39%	-2.70%	-4.46%	10.59%	-14.41%	-13.76%	28.83%	15.37%
NOPAT Growth	-2.04%	-33.65%	75.10%	-15.53%	18.03%	-0.26%	11.98%	-17.17%	-15.23%	34.79%	14.08%
Net Income Growth	-2.95%	-33.82%	67.05%	-15.93%	17.66%	-1.21%	13.18%	-18.25%	-15.87%	24.81%	24.20%
EPS Growth	-0.84%	-35.59%	78.95%	-16.18%	20.61%	0.00%	14.18%	-18.79%	-16.47%	30.05%	26.71%
Operating Cash Flow Growth	2.93%	-10.58%	6.51%	-2.77%	0.07%	2.52%	18.70%	-10.59%	-23.13%	46.52%	9.67%
Free Cash Flow Firm Growth	64.59%	-21.30%	22.75%	-25.50%	-3.77%	-52.40%	165.97%	7.22%	-75.41%	332.39%	41.14%
Invested Capital Growth	-10.88%	-14.12%	-5.40%	0.96%	10.44%	28.87%	3.88%	-5.50%	19.14%	-2.92%	-13.38%
Revenue Q/Q Growth	-0.80%	-1.97%	-1.16%	1.12%	-0.52%	1.32%	1.91%	0.46%	1.27%	1.68%	-0.02%
EBITDA Q/Q Growth	2.72%	-25.95%	34.42%	-2.47%	-3.54%	-1.52%	-0.68%	-14.95%	-4.74%	14.32%	-1.99%
EBIT Q/Q Growth	2.98%	-28.91%	39.88%	-2.96%	-4.15%	-1.94%	-0.94%	-17.12%	-5.38%	16.38%	-2.22%
NOPAT Q/Q Growth	2.99%	-41.05%	72.50%	-12.92%	12.76%	1.54%	0.68%	-17.50%	-5.47%	35.11%	0.25%
Net Income Q/Q Growth	2.86%	-41.25%	68.25%	-11.23%	12.79%	1.57%	0.35%	-17.73%	-6.87%	41.25%	0.56%
EPS Q/Q Growth	1.72%	-44.73%	76.62%	-11.97%	13.64%	1.85%	0.32%	-18.79%	-6.99%	44.27%	0.86%
Operating Cash Flow Q/Q Growth	2.07%	-2.16%	-0.54%	-2.08%	3.49%	3.57%	-0.19%	4.49%	-14.49%	14.11%	3.35%
Free Cash Flow Firm Q/Q Growth	30.34%	-21.79%	46.76%	-16.03%	1.77%	3.84%	-10.66%	13.00%	-56.38%	35.47%	29.51%
Invested Capital Q/Q Growth	-0.03%	-6.76%	-4.00%	-2.38%	2.49%	1.97%	6.75%	-4.91%	5.19%	4.41%	-7.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	58.51%	58.62%	60.04%	60.05%	59.39%	59.42%	60.82%	59.55%	57.04%	58.21%	60.50%
EBITDA Margin	23.15%	20.19%	28.17%	27.06%	26.49%	25.27%	26.41%	21.92%	18.69%	21.54%	23.81%
Operating Margin	20.59%	17.39%	26.03%	23.99%	23.76%	22.65%	23.59%	19.13%	16.10%	20.48%	21.23%
EBIT Margin	20.59%	17.39%	25.25%	23.99%	23.21%	21.96%	23.14%	18.72%	15.66%	18.63%	20.80%
Profit (Net Income) Margin	13.54%	9.65%	17.02%	14.07%	16.46%	16.10%	17.36%	13.42%	10.95%	12.62%	15.17%
Tax Burden Percent	66.20%	56.03%	69.18%	62.35%	73.85%	76.55%	78.42%	75.74%	73.95%	72.38%	77.07%
Interest Burden Percent	99.33%	99.07%	97.42%	94.07%	96.04%	95.79%	95.70%	94.64%	94.56%	93.60%	94.62%
Effective Tax Rate	33.80%	43.97%	30.82%	37.65%	26.15%	23.45%	21.58%	24.26%	26.05%	27.62%	22.93%
Return on Invested Capital (ROIC)	34.44%	26.09%	50.81%	43.94%	49.05%	40.73%	39.73%	33.21%	26.44%	33.26%	41.28%
ROIC Less NNEP Spread (ROIC-NNEP)	34.12%	25.82%	48.03%	41.26%	45.87%	37.66%	37.00%	30.38%	24.05%	27.76%	37.95%
Return on Net Nonoperating Assets (RNNOA)	84.87%	204.78%	-19,206.37%	1,628.37%	1,113.67%	628.67%	305.05%	192.47%	194.94%	245.24%	364.98%
Return on Equity (ROE)	119.31%	230.87%	-19,155.56%	1,672.31%	1,162.73%	669.40%	344.79%	225.68%	221.38%	278.50%	406.26%
Cash Return on Invested Capital (CROIC)	45.95%	41.29%	56.37%	42.99%	39.13%	15.51%	35.92%	38.87%	8.98%	36.23%	55.62%
Operating Return on Assets (OROA)	25.92%	21.97%	31.90%	29.90%	29.05%	25.34%	24.62%	21.07%	18.28%	22.56%	25.78%
Return on Assets (ROA)	17.05%	12.19%	21.50%	17.53%	20.60%	18.58%	18.48%	15.10%	12.78%	15.28%	18.80%
Return on Common Equity (ROCE)	104.97%	145.65%	-384,530.04%	-1,948.88%	-428.10%	13.30%	178.73%	147.26%	125.83%	159.55%	222.21%
Return on Equity Simple (ROE_SIMPLE)	204.28%	-517.73%	-1,064.20%	-3,623.33%	-2,507.84%	2,159.83%	384.93%	383.91%	490.52%	403.12%	1,438.21%
Net Operating Profit after Tax (NOPAT)	2,355	1,563	2,736	2,311	2,728	2,721	3,047	2,524	2,139	2,883	3,289
NOPAT Margin	13.63%	9.75%	18.01%	14.96%	17.55%	17.34%	18.50%	14.49%	11.91%	14.82%	16.36%
Net Nonoperating Expense Percent (NNEP)	0.33%	0.27%	2.78%	2.67%	3.18%	3.07%	2.73%	2.83%	2.39%	5.50%	3.33%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	22.35%	30.33%	38.73%
Cost of Revenue to Revenue	41.49%	41.38%	39.96%	39.95%	40.61%	40.58%	39.18%	40.45%	42.96%	41.79%	39.50%
SG&A Expenses to Revenue	34.62%	34.08%	33.85%	34.94%	34.67%	35.53%	36.54%	36.78%	36.54%	36.75%	38.45%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	37.92%	41.22%	34.01%	36.06%	35.62%	36.77%	37.23%	40.43%	40.94%	37.73%	39.27%
Earnings before Interest and Taxes (EBIT)	3,557	2,789	3,837	3,707	3,607	3,446	3,811	3,262	2,813	3,624	4,181
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,999	3,238	4,280	4,182	4,118	3,965	4,350	3,818	3,358	4,191	4,786
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	44.32	0.00	0.00	0.00	0.00	455.60	91.25	111.74	155.64	104.85	348.38
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.94	3.07	3.22	3.69	2.93	3.40	4.12	3.91	3.47	3.28	3.67
Price to Earnings (P/E)	23.28	35.52	20.05	28.16	18.95	22.52	25.16	31.42	34.96	27.76	25.56
Dividend Yield	2.55%	2.74%	2.82%	2.45%	3.17%	2.75%	2.21%	2.22%	2.49%	2.46%	2.19%
Earnings Yield	4.30%	2.82%	4.99%	3.55%	5.28%	4.44%	3.98%	3.18%	2.86%	3.60%	3.91%
Enterprise Value to Invested Capital (EV/IC)	8.70	9.94	10.39	11.79	8.81	8.07	9.58	10.13	8.05	8.41	10.96
Enterprise Value to Revenue (EV/Rev)	3.24	3.43	3.58	4.03	3.31	3.87	4.55	4.30	3.94	3.69	4.03
Enterprise Value to EBITDA (EV/EBITDA)	14.02	16.98	12.71	14.91	12.49	15.31	17.21	19.60	21.09	17.13	16.93
Enterprise Value to EBIT (EV/EBIT)	15.76	19.72	14.18	16.82	14.26	17.62	19.65	22.94	25.17	19.81	19.38
Enterprise Value to NOPAT (EV/NOPAT)	23.80	35.20	19.89	26.97	18.85	22.31	24.57	29.65	33.10	24.90	24.64
Enterprise Value to Operating Cash Flow (EV/OCF)	16.99	18.65	17.32	20.41	16.83	19.38	20.13	22.50	27.70	19.17	19.73
Enterprise Value to Free Cash Flow (EV/FCFF)	17.84	22.24	17.93	27.57	23.63	58.62	27.18	25.33	97.49	22.86	18.28
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	4.44	-148.82	384.29	27.07	32.31	14.06	6.90	7.46	10.88	8.93	14.61
Long-Term Debt to Equity	4.08	-141.95	383.53	27.02	32.25	13.14	6.66	7.41	10.84	8.59	13.40
Financial Leverage	2.49	7.93	-399.85	39.46	24.28	16.69	8.24	6.33	8.11	8.83	9.62
Leverage Ratio	7.00	18.94	-891.04	95.38	56.45	36.02	18.66	14.94	17.32	18.22	21.61
Compound Leverage Factor	6.95	18.76	-868.05	89.72	54.21	34.50	17.86	14.14	16.37	17.05	20.45
Debt to Total Capital	81.61%	100.68%	99.74%	96.44%	97.00%	93.36%	87.35%	88.18%	91.58%	89.93%	93.59%
Short-Term Debt to Total Capital	6.69%	4.64%	0.20%	0.16%	0.18%	6.12%	3.07%	0.62%	0.26%	3.47%	7.77%
Long-Term Debt to Total Capital	74.92%	96.03%	99.54%	96.28%	96.82%	87.25%	84.28%	87.56%	91.32%	86.46%	85.82%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.19%	3.92%	3.97%	4.44%	4.56%	5.25%	4.11%	4.41%	4.23%	3.66%	3.91%
Common Equity to Total Capital	15.20%	-4.60%	-3.71%	-0.88%	-1.55%	1.39%	8.54%	7.41%	4.19%	6.41%	2.50%
Debt to EBITDA	1.54	2.02	1.53	1.57	1.55	1.98	1.75	1.90	2.61	2.04	1.66
Net Debt to EBITDA	1.27	1.72	1.22	1.21	1.37	1.76	1.54	1.68	2.38	1.81	1.43
Long-Term Debt to EBITDA	1.41	1.93	1.52	1.57	1.54	1.85	1.69	1.88	2.60	1.96	1.52
Debt to NOPAT	2.61	4.19	2.39	2.85	2.33	2.88	2.49	2.87	4.10	2.96	2.42
Net Debt to NOPAT	2.15	3.57	1.91	2.18	2.07	2.56	2.20	2.54	3.74	2.63	2.08
Long-Term Debt to NOPAT	2.40	4.00	2.38	2.84	2.33	2.70	2.41	2.85	4.09	2.85	2.22
Altman Z-Score	6.72	6.87	7.13	7.32	7.07	6.12	6.65	7.07	6.51	6.60	7.22
Noncontrolling Interest Sharing Ratio	12.01%	36.91%	-1,907.41%	216.54%	136.82%	98.01%	48.16%	34.75%	43.16%	42.71%	45.30%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.23	1.24	1.31	1.36	1.14	1.03	0.99	1.09	1.28	1.11	0.92
Quick Ratio	0.67	0.68	0.82	0.88	0.64	0.58	0.49	0.53	0.57	0.54	0.45
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	3,142	2,473	3,035	2,261	2,176	1,036	2,755	2,954	726	3,140	4,432
Operating Cash Flow to CapEx	435.67%	426.77%	589.31%	552.26%	700.92%	935.22%	907.07%	586.42%	393.84%	531.21%	732.09%
Free Cash Flow to Firm to Interest Expense	130.91	95.10	30.66	10.28	15.22	7.14	16.80	16.88	4.35	10.94	15.18
Operating Cash Flow to Interest Expense	137.42	113.42	31.73	13.88	21.37	21.61	22.68	19.00	15.31	13.05	14.07
Operating Cash Flow Less CapEx to Interest Expense	105.88	86.85	26.34	11.37	18.32	19.30	20.18	15.76	11.42	10.59	12.14
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.26	1.26	1.26	1.25	1.25	1.15	1.06	1.13	1.17	1.21	1.24
Accounts Receivable Turnover	10.84	10.76	10.71	10.69	10.79	11.05	12.18	13.60	12.83	12.59	12.94
Inventory Turnover	5.11	5.18	5.17	5.16	5.11	4.81	4.20	4.19	4.10	4.06	4.05
Fixed Asset Turnover	4.23	4.07	3.98	3.91	3.91	4.11	4.41	4.68	4.47	4.38	4.46
Accounts Payable Turnover	5.57	5.67	5.44	5.29	5.19	5.18	4.91	4.91	5.10	5.01	4.53
Days Sales Outstanding (DSO)	33.68	33.91	34.09	34.14	33.81	33.03	29.96	26.83	28.45	28.98	28.21
Days Inventory Outstanding (DIO)	71.47	70.47	70.66	70.71	71.43	75.95	86.90	87.16	89.04	89.96	90.12
Days Payable Outstanding (DPO)	65.54	64.39	67.15	69.05	70.36	70.47	74.37	74.39	71.64	72.92	80.52
Cash Conversion Cycle (CCC)	39.61	39.99	37.60	35.80	34.88	38.50	42.49	39.60	45.85	46.02	37.82
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	6,444	5,534	5,235	5,285	5,837	7,522	7,814	7,384	8,797	8,540	7,397
Invested Capital Turnover	2.53	2.68	2.82	2.94	2.80	2.35	2.15	2.29	2.22	2.24	2.52
Increase / (Decrease) in Invested Capital	-787	-910	-299	50	552	1,685	292	-430	1,413	-257	-1,143
Enterprise Value (EV)	56,048	54,996	54,412	62,334	51,425	60,710	74,869	74,828	70,806	71,784	81,041
Market Capitalization	50,749	49,163	48,934	56,989	45,486	53,305	67,798	68,053	62,410	63,853	73,856
Book Value per Share	$1.26	($0.33)	($0.27)	($0.07)	($0.12)	$0.14	$0.87	$0.72	$0.48	$0.74	$0.26
Tangible Book Value per Share	($2.83)	($4.18)	($4.12)	($4.12)	($4.92)	($7.07)	($6.97)	($6.09)	($5.83)	($5.69)	($5.89)
Total Capital	7,533	6,504	6,550	6,820	6,563	8,405	8,702	8,216	9,572	9,506	8,493
Total Debt	6,148	6,548	6,533	6,577	6,366	7,847	7,601	7,245	8,766	8,549	7,949
Total Long-Term Debt	5,644	6,246	6,520	6,566	6,354	7,333	7,334	7,194	8,741	8,219	7,289
Net Debt	5,059	5,578	5,218	5,042	5,640	6,964	6,713	6,413	7,991	7,583	6,853
Capital Expenditures (CapEx)	757	691	533	553	436	335	410	567	649	705	561
Debt-free, Cash-free Net Working Capital (DFCFNWC)	332	182	-269	-293	-262	-228	-687	-435	359	-98	-878
Debt-free Net Working Capital (DFNWC)	1,421	1,152	1,046	1,242	464	655	201	397	1,134	868	218
Net Working Capital (NWC)	917	850	1,033	1,231	452	141	-66	346	1,109	538	-442
Net Nonoperating Expense (NNE)	16	15	150	137	170	194	187	186	172	428	240
Net Nonoperating Obligations (NNO)	5,059	5,578	5,218	5,042	5,640	6,964	6,713	6,413	7,991	7,583	6,853
Total Depreciation and Amortization (D&A)	442	449	443	475	511	519	539	556	545	567	605
Debt-free, Cash-free Net Working Capital to Revenue	1.92%	1.14%	-1.77%	-1.90%	-1.69%	-1.45%	-4.17%	-2.50%	2.00%	-0.50%	-4.37%
Debt-free Net Working Capital to Revenue	8.22%	7.18%	6.88%	8.04%	2.99%	4.17%	1.22%	2.28%	6.31%	4.46%	1.08%
Net Working Capital to Revenue	5.31%	5.30%	6.80%	7.97%	2.91%	0.90%	-0.40%	1.99%	6.17%	2.77%	-2.20%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.38	$1.53	$2.74	$0.00	$2.76	$2.76	$3.15	$2.56	$2.13	$2.78	$3.53
Adjusted Weighted Average Basic Shares Outstanding	907.08M	892.74M	882.86M	0.00	861.68M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M
Adjusted Diluted Earnings per Share	$2.36	$1.52	$2.72	$0.00	$2.75	$2.75	$3.14	$2.55	$2.13	$2.77	$3.51
Adjusted Weighted Average Diluted Shares Outstanding	907.08M	892.74M	882.86M	0.00	861.68M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	907.08M	892.74M	882.86M	0.00	861.68M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M
Normalized Net Operating Profit after Tax (NOPAT)	2,355	1,563	2,736	2,311	2,728	2,721	3,047	2,956	2,672	2,883	3,289
Normalized NOPAT Margin	13.63%	9.75%	18.01%	14.96%	17.55%	17.34%	18.50%	16.97%	14.87%	14.82%	16.36%
Pre Tax Income Margin	20.45%	17.23%	24.60%	22.56%	22.29%	21.03%	22.14%	17.72%	14.80%	17.43%	19.68%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	148.21	107.27	38.76	16.85	25.22	23.77	23.24	18.64	16.84	12.63	14.32
NOPAT to Interest Expense	98.12	60.10	27.64	10.51	19.08	18.76	18.58	14.42	12.81	10.05	11.27
EBIT Less CapEx to Interest Expense	116.67	80.69	33.37	14.34	22.17	21.46	20.74	15.40	12.96	10.17	12.40
NOPAT Less CapEx to Interest Expense	66.58	33.52	22.25	7.99	16.03	16.45	16.08	11.18	8.92	7.59	9.34
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	61.82%	96.45%	58.31%	70.33%	62.20%	63.87%	61.29%	71.81%	85.97%	71.24%	58.68%
Augmented Payout Ratio	127.23%	196.64%	109.94%	134.68%	110.59%	111.44%	112.90%	128.27%	152.47%	117.19%	115.71%

This table displays calculated financial ratios and metrics derived from Colgate-Palmolive's official financial filings.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.13%	8.43%	7.54%	10.33%	6.93%	6.18%	4.89%	2.40%	-0.10%	-3.04%	1.03%
EBITDA Growth	-34.15%	-22.60%	10.79%	8.63%	279.50%	58.14%	11.62%	4.92%	-0.82%	-1.96%	-1.55%
EBIT Growth	-46.11%	-25.18%	11.70%	8.80%	473.26%	66.67%	12.12%	5.03%	-0.75%	-2.05%	-1.22%
NOPAT Growth	-68.93%	2.84%	-12.70%	11.05%	1,153.16%	17.66%	41.42%	4.25%	0.96%	3.85%	-0.03%
Net Income Growth	-77.13%	-31.34%	-16.43%	9.53%	1,667.44%	76.09%	43.63%	3.88%	2.24%	-0.41%	0.78%
EPS Growth	-94.12%	-31.82%	-16.67%	16.22%	8,500.00%	84.44%	48.33%	4.65%	3.49%	2.41%	2.25%
Operating Cash Flow Growth	-39.15%	90.41%	36.74%	18.89%	68.80%	-7.35%	37.12%	1.30%	11.71%	-11.89%	-10.71%
Free Cash Flow Firm Growth	-309.91%	-148.35%	-124.25%	683.84%	180.29%	405.58%	695.55%	-0.90%	82.65%	12.60%	-77.73%
Invested Capital Growth	19.14%	13.50%	10.40%	-2.20%	-2.92%	-2.81%	-5.15%	-1.72%	-13.38%	-4.10%	6.80%
Revenue Q/Q Growth	3.91%	3.05%	1.09%	1.93%	0.71%	2.32%	-0.14%	-0.49%	-1.75%	-0.69%	4.05%
EBITDA Q/Q Growth	-69.79%	130.75%	50.61%	3.49%	5.53%	-2.08%	6.30%	-2.72%	-0.25%	-4.95%	4.86%
EBIT Q/Q Growth	-79.94%	228.88%	58.37%	4.11%	5.72%	-2.38%	6.54%	-2.47%	-0.09%	-5.64%	5.28%
NOPAT Q/Q Growth	-90.91%	919.43%	-12.59%	37.12%	2.56%	-4.28%	5.06%	1.07%	-0.67%	-1.54%	1.14%
Net Income Q/Q Growth	-93.70%	862.79%	28.99%	39.89%	1.74%	-4.08%	5.21%	1.17%	0.13%	-6.56%	6.47%
EPS Q/Q Growth	-98.65%	4,400.00%	33.33%	43.33%	0.00%	-3.49%	7.23%	1.12%	-1.11%	-4.49%	7.06%
Operating Cash Flow Q/Q Growth	-30.55%	9.21%	-1.77%	59.56%	-1.39%	-40.05%	45.37%	17.88%	8.74%	-52.72%	47.33%
Free Cash Flow Firm Q/Q Growth	-1,168.77%	75.05%	36.75%	564.69%	9.47%	-5.02%	23.26%	-22.67%	101.76%	-41.45%	-75.62%
Invested Capital Q/Q Growth	5.19%	-3.77%	0.24%	-3.61%	4.41%	-3.67%	-2.18%	-0.12%	-7.97%	6.66%	8.94%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	55.61%	56.86%	57.80%	58.54%	59.60%	60.00%	60.62%	61.08%	60.30%	60.82%	60.06%
EBITDA Margin	6.96%	15.58%	23.21%	23.56%	24.69%	23.20%	24.69%	24.14%	24.51%	23.46%	23.64%
Operating Margin	4.36%	19.06%	20.20%	20.94%	21.66%	20.67%	21.59%	21.16%	21.52%	21.91%	21.14%
EBIT Margin	4.04%	12.89%	20.20%	20.63%	21.66%	20.24%	21.59%	21.16%	21.52%	20.44%	20.68%
Profit (Net Income) Margin	0.93%	8.68%	11.07%	15.20%	15.35%	14.39%	15.16%	15.42%	15.71%	14.78%	15.13%
Tax Burden Percent	32.58%	73.80%	60.20%	78.14%	76.92%	75.39%	75.94%	78.70%	78.25%	76.18%	76.76%
Interest Burden Percent	70.59%	91.22%	91.07%	94.28%	92.16%	94.34%	92.49%	92.58%	93.33%	94.92%	95.27%
Effective Tax Rate	67.42%	26.20%	39.80%	21.86%	23.08%	24.61%	24.06%	21.30%	21.75%	23.82%	23.24%
Return on Invested Capital (ROIC)	3.16%	32.39%	28.09%	37.85%	37.39%	36.88%	39.64%	41.29%	42.47%	41.32%	38.99%
ROIC Less NNEP Spread (ROIC-NNEP)	2.84%	28.91%	27.40%	37.09%	36.56%	36.11%	38.85%	40.46%	41.70%	40.05%	38.25%
Return on Net Nonoperating Assets (RNNOA)	23.02%	370.40%	480.21%	383.45%	322.98%	542.34%	767.08%	487.88%	401.06%	438.04%	376.73%
Return on Equity (ROE)	26.18%	402.79%	508.30%	421.30%	360.38%	579.23%	806.73%	529.18%	443.53%	479.36%	415.72%
Cash Return on Invested Capital (CROIC)	8.98%	14.43%	15.50%	28.03%	36.23%	38.87%	44.57%	42.21%	55.62%	45.38%	33.32%
Operating Return on Assets (OROA)	4.72%	14.83%	23.62%	24.42%	26.23%	24.41%	26.39%	25.93%	26.67%	24.55%	24.37%
Return on Assets (ROA)	1.08%	9.98%	12.95%	17.99%	18.60%	17.36%	18.53%	18.89%	19.47%	17.75%	17.82%
Return on Common Equity (ROCE)	14.88%	110.04%	60.55%	177.01%	206.45%	124.52%	59.72%	181.51%	242.60%	210.56%	223.58%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	-2,614.06%	0.00%	0.00%	1,204.35%	2,441.46%	697.01%	0.00%	839.12%	0.00%
Net Operating Profit after Tax (NOPAT)	66	671	586	804	825	789	829	838	833	820	829
NOPAT Margin	1.42%	14.06%	12.16%	16.36%	16.66%	15.58%	16.40%	16.65%	16.84%	16.69%	16.22%
Net Nonoperating Expense Percent (NNEP)	0.32%	3.48%	0.68%	0.76%	0.83%	0.77%	0.79%	0.83%	0.77%	1.27%	0.74%
Return On Investment Capital (ROIC_SIMPLE)	0.69%	-	-	-	8.67%	-	-	-	9.80%	9.11%	8.45%
Cost of Revenue to Revenue	44.39%	43.14%	42.20%	41.46%	40.40%	40.00%	39.38%	38.92%	39.70%	39.18%	39.94%
SG&A Expenses to Revenue	35.28%	36.86%	36.67%	37.07%	36.42%	37.83%	38.34%	39.32%	38.32%	38.65%	38.41%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	51.24%	37.80%	37.60%	37.60%	37.94%	39.33%	39.03%	39.92%	38.79%	38.91%	38.92%
Earnings before Interest and Taxes (EBIT)	187	615	974	1,014	1,072	1,025	1,092	1,065	1,064	1,004	1,057
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	322	743	1,119	1,158	1,222	1,175	1,249	1,215	1,212	1,152	1,208
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	155.64	0.00	0.00	0.00	104.85	320.51	644.00	194.02	348.38	208.31	104.31
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.47	3.30	3.32	2.99	3.28	3.73	3.96	4.20	3.67	3.79	3.66
Price to Earnings (P/E)	34.96	37.86	41.44	36.01	27.76	28.23	27.89	29.42	25.56	26.11	25.18
Dividend Yield	2.49%	2.58%	2.53%	2.75%	2.46%	2.14%	2.01%	1.90%	2.19%	2.15%	2.24%
Earnings Yield	2.86%	2.64%	2.41%	2.78%	3.60%	3.54%	3.59%	3.40%	3.91%	3.83%	3.97%
Enterprise Value to Invested Capital (EV/IC)	8.05	8.15	8.32	7.99	8.41	9.93	10.83	11.45	10.96	10.54	9.44
Enterprise Value to Revenue (EV/Rev)	3.94	3.76	3.78	3.41	3.69	4.14	4.36	4.58	4.03	4.17	4.06
Enterprise Value to EBITDA (EV/EBITDA)	21.09	21.96	19.75	17.82	17.13	17.68	18.00	18.84	16.93	17.46	17.10
Enterprise Value to EBIT (EV/EBIT)	25.17	26.47	23.28	20.98	19.81	20.26	20.55	21.52	19.38	19.99	19.56
Enterprise Value to NOPAT (EV/NOPAT)	33.10	31.99	34.40	30.61	24.90	27.18	26.83	28.04	24.64	25.04	24.43
Enterprise Value to Operating Cash Flow (EV/OCF)	27.70	23.74	22.78	19.91	19.17	22.14	22.01	23.15	19.73	20.65	20.69
Enterprise Value to Free Cash Flow (EV/FCFF)	97.49	60.02	56.34	28.18	22.86	25.19	23.65	26.88	18.28	22.73	29.25
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	10.88	20.96	28.54	21.49	8.93	14.08	18.00	10.09	14.61	11.28	8.33
Long-Term Debt to Equity	10.84	20.87	28.43	21.40	8.59	13.21	16.90	9.46	13.40	8.96	6.79
Financial Leverage	8.11	12.81	17.52	10.34	8.83	15.02	19.74	12.06	9.62	10.94	9.85
Leverage Ratio	17.32	27.66	36.58	22.16	18.22	31.42	41.04	26.42	21.61	24.61	22.13
Compound Leverage Factor	12.22	25.23	33.32	20.89	16.79	29.65	37.96	24.46	20.17	23.36	21.08
Debt to Total Capital	91.58%	95.45%	96.61%	95.55%	89.93%	93.37%	94.74%	90.98%	93.59%	91.86%	89.28%
Short-Term Debt to Total Capital	0.26%	0.40%	0.38%	0.37%	3.47%	5.78%	5.79%	5.68%	7.77%	18.86%	16.45%
Long-Term Debt to Total Capital	91.32%	95.05%	96.24%	95.18%	86.46%	87.59%	88.95%	85.30%	85.82%	72.99%	72.82%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	4.23%	4.62%	4.07%	4.55%	3.66%	4.16%	3.92%	4.32%	3.91%	4.11%	3.57%
Common Equity to Total Capital	4.19%	-0.06%	-0.69%	-0.10%	6.41%	2.47%	1.34%	4.69%	2.50%	4.03%	7.16%
Debt to EBITDA	2.61	2.84	2.52	2.38	2.04	1.88	1.79	1.73	1.66	1.74	1.85
Net Debt to EBITDA	2.38	2.56	2.29	2.12	1.81	1.65	1.56	1.47	1.43	1.50	1.59
Long-Term Debt to EBITDA	2.60	2.82	2.51	2.37	1.96	1.76	1.68	1.62	1.52	1.38	1.51
Debt to NOPAT	4.10	4.13	4.38	4.09	2.96	2.89	2.67	2.57	2.42	2.49	2.64
Net Debt to NOPAT	3.74	3.73	3.98	3.64	2.63	2.53	2.33	2.19	2.08	2.16	2.27
Long-Term Debt to NOPAT	4.09	4.11	4.36	4.07	2.85	2.71	2.51	2.41	2.22	1.98	2.15
Altman Z-Score	5.96	5.73	5.84	5.79	6.08	6.32	6.59	6.76	6.58	6.39	6.11
Noncontrolling Interest Sharing Ratio	43.16%	72.68%	88.09%	57.98%	42.71%	78.50%	92.60%	65.70%	45.30%	56.07%	46.22%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.28	1.23	1.17	1.16	1.11	1.06	1.06	1.04	0.92	0.85	0.89
Quick Ratio	0.57	0.55	0.53	0.55	0.54	0.54	0.55	0.53	0.45	0.41	0.44
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,347	-336	-213	988	1,082	1,027	1,266	979	1,976	1,157	282
Operating Cash Flow to CapEx	304.52%	450.92%	392.39%	715.53%	576.65%	540.48%	846.15%	870.90%	689.67%	483.87%	818.52%
Free Cash Flow to Firm to Interest Expense	-19.52	-6.23	-7.33	0.00	0.00	17.71	57.56	42.57	10.45	17.53	3.97
Operating Cash Flow to Interest Expense	9.75	13.61	24.90	0.00	0.00	11.74	45.00	50.74	6.71	9.09	12.45
Operating Cash Flow Less CapEx to Interest Expense	6.55	10.59	18.55	0.00	0.00	9.57	39.68	44.91	5.74	7.21	10.93
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.17	1.15	1.17	1.18	1.21	1.21	1.22	1.23	1.24	1.20	1.18
Accounts Receivable Turnover	12.83	11.75	11.87	12.75	12.59	11.61	11.48	12.23	12.94	11.28	11.12
Inventory Turnover	4.10	3.94	3.98	4.09	4.06	4.03	4.07	4.02	4.05	3.88	3.90
Fixed Asset Turnover	4.47	4.52	4.56	4.49	4.38	4.46	4.53	4.55	4.46	4.48	4.48
Accounts Payable Turnover	5.10	4.98	5.28	5.42	5.01	4.98	5.20	5.13	4.53	4.55	4.71
Days Sales Outstanding (DSO)	28.45	31.07	30.74	28.63	28.98	31.44	31.78	29.85	28.21	32.37	32.83
Days Inventory Outstanding (DIO)	89.04	92.60	91.78	89.27	89.96	90.68	89.73	90.87	90.12	94.04	93.53
Days Payable Outstanding (DPO)	71.64	73.25	69.13	67.40	72.92	73.35	70.25	71.08	80.52	80.24	77.45
Cash Conversion Cycle (CCC)	45.85	50.42	53.40	50.50	46.02	48.77	51.27	49.64	37.82	46.18	48.92
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	8,797	8,465	8,485	8,179	8,540	8,227	8,048	8,038	7,397	7,890	8,595
Invested Capital Turnover	2.22	2.30	2.31	2.31	2.24	2.37	2.42	2.48	2.52	2.48	2.40
Increase / (Decrease) in Invested Capital	1,413	1,007	799	-184	-257	-238	-437	-141	-1,143	-337	547
Enterprise Value (EV)	70,806	68,970	70,588	65,328	71,784	81,714	87,137	92,003	81,041	83,145	81,121
Market Capitalization	62,410	60,499	62,039	57,140	63,853	73,717	79,212	84,400	73,856	75,618	73,228
Book Value per Share	$0.48	($0.01)	($0.08)	($0.01)	$0.74	$0.28	$0.15	$0.53	$0.26	$0.45	$0.87
Tangible Book Value per Share	($5.83)	($6.38)	($6.43)	($6.29)	($5.69)	($6.03)	($6.11)	($5.86)	($5.89)	($5.86)	($6.04)
Total Capital	9,572	9,332	9,304	9,130	9,506	9,306	9,158	9,272	8,493	9,002	9,810
Total Debt	8,766	8,907	8,989	8,724	8,549	8,689	8,676	8,436	7,949	8,269	8,758
Total Long-Term Debt	8,741	8,870	8,954	8,690	8,219	8,151	8,146	7,909	7,289	6,571	7,144
Net Debt	7,991	8,040	8,170	7,773	7,583	7,610	7,566	7,202	6,853	7,157	7,543
Capital Expenditures (CapEx)	221	163	184	161	197	126	117	134	184	124	108
Debt-free, Cash-free Net Working Capital (DFCFNWC)	359	195	21	-162	-98	-215	-284	-466	-878	-461	-380
Debt-free Net Working Capital (DFNWC)	1,134	1,062	840	789	868	864	826	768	218	651	835
Net Working Capital (NWC)	1,109	1,025	805	755	538	326	296	241	-442	-1,047	-779
Net Nonoperating Expense (NNE)	23	257	52	57	65	60	62	62	56	94	56
Net Nonoperating Obligations (NNO)	7,991	8,040	8,170	7,773	7,583	7,610	7,566	7,202	6,853	7,157	7,543
Total Depreciation and Amortization (D&A)	135	128	145	144	150	150	157	150	148	148	151
Debt-free, Cash-free Net Working Capital to Revenue	2.00%	1.06%	0.11%	-0.85%	-0.50%	-1.09%	-1.42%	-2.32%	-4.37%	-2.31%	-1.90%
Debt-free Net Working Capital to Revenue	6.31%	5.79%	4.50%	4.12%	4.46%	4.37%	4.13%	3.82%	1.08%	3.26%	4.18%
Net Working Capital to Revenue	6.17%	5.59%	4.31%	3.95%	2.77%	1.65%	1.48%	1.20%	-2.20%	-5.25%	-3.90%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.45	$0.61	$0.86	$0.86	$0.83	$0.89	$0.90	$0.91	$0.85	$0.92
Adjusted Weighted Average Basic Shares Outstanding	830.38M	829.57M	826.69M	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M	810.42M	808.22M
Adjusted Diluted Earnings per Share	$0.01	$0.45	$0.60	$0.86	$0.86	$0.83	$0.89	$0.90	$0.89	$0.85	$0.91
Adjusted Weighted Average Diluted Shares Outstanding	830.38M	829.57M	826.69M	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M	810.42M	808.22M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	830.38M	829.57M	826.69M	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M	810.42M	808.22M
Normalized Net Operating Profit after Tax (NOPAT)	141	671	586	804	825	789	829	838	833	820	829
Normalized NOPAT Margin	3.05%	14.06%	12.16%	16.36%	16.66%	15.58%	16.40%	16.65%	16.84%	16.69%	16.22%
Pre Tax Income Margin	2.85%	11.76%	18.39%	19.45%	19.96%	19.09%	19.97%	19.59%	20.08%	19.41%	19.71%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.71	11.39	33.59	0.00	0.00	17.67	49.64	46.30	5.63	15.21	14.89
NOPAT to Interest Expense	0.95	12.42	20.22	0.00	0.00	13.61	37.69	36.44	4.41	12.42	11.68
EBIT Less CapEx to Interest Expense	-0.49	8.37	27.24	0.00	0.00	15.50	44.32	40.48	4.66	13.33	13.37
NOPAT Less CapEx to Interest Expense	-2.25	9.40	13.88	0.00	0.00	11.44	32.38	30.62	3.43	10.54	10.16
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	85.97%	95.78%	103.05%	99.42%	71.24%	63.29%	58.91%	58.74%	58.68%	59.13%	59.04%
Augmented Payout Ratio	152.47%	156.41%	166.89%	173.99%	117.19%	115.88%	111.06%	109.17%	115.71%	108.83%	100.52%

Key Financial Trends

Colgate-Palmolive has demonstrated steady financial performance and maintained a resilient business model throughout the last four years. Here are the key trends and takeaways from their income statements, balance sheets, and cash flow statements:

Consistent revenue growth: Operating revenues have grown from approximately $4.77 billion in Q1 2023 to around $5.11 billion in Q2 2025, indicating steady top-line expansion.
Strong gross profit margins: Gross profit consistently ranges around $3 billion per quarter, reflecting effective cost management and pricing power despite inflationary pressures.
Increasing net income: Net income attributable to common shareholders increased from $372 million in Q1 2023 to $743 million in Q2 2025. This shows improving profitability over time.
Robust operating cash flow: Net cash from continuing operating activities rose significantly from $735 million in Q1 2023 to $884 million in Q2 2025, supporting stable operations and investments.
Moderate capital expenditures: Property, plant, and equipment purchases have remained consistent at approx. $100-$180 million per quarter, indicating sustainable reinvestment in the business.
Effective capital allocation: The company has consistently repurchased common equity (e.g., $232 million in Q2 2025) and sustained dividend payments ($0.52 per share in Q2 2025), rewarding shareholders.
Manageable debt levels: Long-term debt fluctuates around $7 billion, with repayments and issuances balancing out. Short-term debt varies but remains below $2 billion.
Stable total assets: Total assets increased modestly from about $16.17 billion in Q1 2023 to $17.47 billion in Q2 2025, showing steady asset base growth.
Equity fluctuations: Total common equity is relatively low compared to liabilities, ranging around $0.3 to $0.7 billion, partly due to large treasury stock balances.
Pressure on other comprehensive income: Accumulated other comprehensive income shows a persistent negative balance (~$3.9 to $4.2 billion), reflecting currency and other adjustments that may impact equity.

Overall, Colgate-Palmolive shows consistent revenue and profit growth with strong cash flow generation supporting dividends and share repurchases. The company manages capital expenditures prudently and maintains a stable balance sheet. Investors may find the reliable earnings and shareholder returns attractive despite some equity volatility and non-operating adjustments.

08/29/25 06:13 AM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About Colgate-Palmolive's Financials

When does Colgate-Palmolive's fiscal year end?

According to the most recent income statement we have on file, Colgate-Palmolive's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Colgate-Palmolive's net income changed over the last 10 years?

Colgate-Palmolive's net income appears to be on an upward trend, with a most recent value of $3.05 billion in 2024, rising from $2.34 billion in 2014. The previous period was $2.46 billion in 2023. View Colgate-Palmolive's forecast to see where analysts expect Colgate-Palmolive to go next.

What is Colgate-Palmolive's operating income?

Colgate-Palmolive's total operating income in 2024 was $4.27 billion, based on the following breakdown:

Total Gross Profit: $12.16 billion
Total Operating Expenses: $7.89 billion

How has Colgate-Palmolive's revenue changed over the last 10 years?

Over the last 10 years, Colgate-Palmolive's total revenue changed from $17.28 billion in 2014 to $20.10 billion in 2024, a change of 16.3%.

How much debt does Colgate-Palmolive have?

Colgate-Palmolive's total liabilities were at $15.50 billion at the end of 2024, a 0.4% increase from 2023, and a 28.4% increase since 2014.

How much cash does Colgate-Palmolive have?

In the past 10 years, Colgate-Palmolive's cash and equivalents has ranged from $726 million in 2018 to $1.54 billion in 2017, and is currently $1.10 billion as of their latest financial filing in 2024.

How has Colgate-Palmolive's book value per share changed over the last 10 years?

Over the last 10 years, Colgate-Palmolive's book value per share changed from 1.26 in 2014 to 0.26 in 2024, a change of -79.3%.

Related Companies

This page (NYSE:CL) was last updated on 8/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Colgate-Palmolive (CL) Financials

Key Financial Trends

Financials Breakdown Chart

Frequently Asked Questions About Colgate-Palmolive's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Colgate-Palmolive (CL) Financials

Annual Income Statements for Colgate-Palmolive

Quarterly Income Statements for Colgate-Palmolive

Annual Cash Flow Statements for Colgate-Palmolive

Quarterly Cash Flow Statements for Colgate-Palmolive

Annual Balance Sheets for Colgate-Palmolive

Quarterly Balance Sheets for Colgate-Palmolive

Annual Metrics And Ratios for Colgate-Palmolive

Quarterly Metrics And Ratios for Colgate-Palmolive

Key Financial Trends

Financials Breakdown Chart

Frequently Asked Questions About Colgate-Palmolive's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools